Henryk Lamparczyk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Henryk Lamparczyk has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Aleksandra Chmielewska
Medical University of Gdansk, Faculty of Pharmacy, Hallera 107, PL‐80‐416 Gdansk, Poland
2 shared publications- Lucyna Konieczna
Department of Pharmaceutical Chemistry, Medical University of Gdańsk, Hallera 107, 80-416 Gdańsk, Poland
2 shared publications - Pawel K. Zarzycki
Faculty of Civil Engineering, Environmental and Geodetic Sciences, Koszalin University of Technology, 75-453 Koszalin, Poland
2 shared publications - Alina Plenis
Department of Analytical Chemistry, Faculty of Pharmacy, Medical University of Gdansk, 80-210 Gdansk, Poland
1 shared publication - Ilona Olędzka
Department of Pharmaceutical Chemistry, Medical University of Gdańsk, Hallera 107, 80-416 Gdańsk, Poland
1 shared publication - Piotr Kowalski
Department of Pharmaceutical Chemistry, Medical University of Gdańsk, Hallera 107, 80-416 Gdańsk, Poland
1 shared publication
Latest Publications
- 14 November 2003
- Published by Wiley in Biomedical Chromatography
- Vol. 18 (5) , 311-317
The bioequivalence study of baclofen and lioresal tablets using capillary electrophoresis
A simple and robust analytical method for rapid separation and sensitive quantification of baclofen in human plasma by capillary electrophoresis technique was developed. Electrophoretic separation was optimized and successfully performed using simple sodium tetraborate aqueous solution. Observed detection limit in biological material was 10 ng. Using UV detection at 200 nm excellent linearity (r = 0.999) was observed over the concentration range from 0.025 to 1.0 µg mL−1. The described method has been validated and applied to the quantitative determination of baclofen in human plasma. The bioavailability of Baclofen (Polpharma) and Lioresal (Novartis) in 18 healthy volunteers was investigated. The results indicate bioequivalence of the reference and Baclofen preparations. Copyright © 2003 John Wiley & Sons, Ltd.
- 14 November 2003
- Published by Wiley in Biomedical Chromatography
- Vol. 18 (5) , 311-317
The bioequivalence study of baclofen and lioresal tablets using capillary electrophoresis
A simple and robust analytical method for rapid separation and sensitive quantification of baclofen in human plasma by capillary electrophoresis technique was developed. Electrophoretic separation was optimized and successfully performed using simple sodium tetraborate aqueous solution. Observed detection limit in biological material was 10 ng. Using UV detection at 200 nm excellent linearity (r = 0.999) was observed over the concentration range from 0.025 to 1.0 µg mL−1. The described method has been validated and applied to the quantitative determination of baclofen in human plasma. The bioavailability of Baclofen (Polpharma) and Lioresal (Novartis) in 18 healthy volunteers was investigated. The results indicate bioequivalence of the reference and Baclofen preparations. Copyright © 2003 John Wiley & Sons, Ltd.
- 19 October 2001
- Published by Wiley in Biomedical Chromatography
- Vol. 15 (8) , 513-517
RP‐HPLC method with electrochemical detection for the determination of metoclopramide in serum and its use in pharmacokinetic studies
A rapid and sensitive reversed‐phase high performance liquid chromatographic method has been developed for the determination of metoclopramide in serum. The assay was performed after single extraction with ethyl ether using methyl parahydroxybenzoate as internal standard. Chromatographic separations were performed on C18 stationary phase with a mobile phase composed of methanol–phosphate buffer pH 3 (30:70 v/v). Analytes were detected electrochemically. The quantification limit for metoclopramide in serum was 2 ng mL−1. Linearity of the method was confirmed in the range of 5–120 ng mL−1 (correlation coefficient 0.9998). Within‐day relative standard deviations (RSDs) ranged from 0.3 to 5.5% and between‐day RSDs from 0.8 to 6.0%. The analytical method was successfully applied for the determination of pharmacokinetic parameters after ingestion of 10 mg dose of metoclopramide. Studies were performed on 18 healthy volunteers of both sexes. Copyright © 2001 John Wiley & Sons, Ltd.
- 19 October 2001
- Published by Wiley in Biomedical Chromatography
- Vol. 15 (8) , 513-517
RP‐HPLC method with electrochemical detection for the determination of metoclopramide in serum and its use in pharmacokinetic studies
A rapid and sensitive reversed‐phase high performance liquid chromatographic method has been developed for the determination of metoclopramide in serum. The assay was performed after single extraction with ethyl ether using methyl parahydroxybenzoate as internal standard. Chromatographic separations were performed on C18 stationary phase with a mobile phase composed of methanol–phosphate buffer pH 3 (30:70 v/v). Analytes were detected electrochemically. The quantification limit for metoclopramide in serum was 2 ng mL−1. Linearity of the method was confirmed in the range of 5–120 ng mL−1 (correlation coefficient 0.9998). Within‐day relative standard deviations (RSDs) ranged from 0.3 to 5.5% and between‐day RSDs from 0.8 to 6.0%. The analytical method was successfully applied for the determination of pharmacokinetic parameters after ingestion of 10 mg dose of metoclopramide. Studies were performed on 18 healthy volunteers of both sexes. Copyright © 2001 John Wiley & Sons, Ltd.